The latest research, 'US Thalassemia Market Highlights – 2014', provides the US thalassemia market analysis, competitive landscape, and thalassemia drug sales forecast in the US.
The research includes the US thalassemia market size estimates for 2013, market share forecast for six years to 2019, thalassemia drugs market share, thalassemia drugs sales estimates, thalassemia drugs sales forecast, and thalassemia late stage pipeline products.This research helps executives track competitor drugs sales and market share in the US thalassemia market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the US thalassemia market.
SCOPE OF THE REPORT
What are the drugs marketed in the US for treating thalassemia?
Identify drugs marketed in the US for treating thalassemia including trade name, molecule name, company, and year of launch.
How big is the US thalassemia market?
Find out estimates for the US thalassemia market size in 2013, key products and their sales, and how the market and products advanced from 2010. You will benefit from our accurate country and indication level valuation of products and the market.
What is my competitor’s drugs market share in the US thalassemia market?
You will know the market share of leading thalassemia brands in the US, including generics share.
What are the key molecules in pipeline for thalassemia?
Find out pipeline products in clinical trial phase 3 and phase 2 for the treatment of thalassemia. Our coverage includes molecule, mechanism of action, and the originator.
What is the future of the US thalassemia market?
Gain insights into how the US thalassemia market will advance along with market forecast till 2019. Determine future market events and trends including launch of new drugs and generic erosion of leading molecules.
Future thalassemia drugs forecast in the US
Find out how thalassemia drugs will be positioned in the US in 2019, with drug sales forecast and drug market share analysis for both marketed products and pipeline products.
Highlights of the Research:
Marketed Thalassemia Drugs in the US
The US Thalassemia Market Analysis
Thalassemia Drugs Sales Analysis in the US
Competitive Landscape in the US Thalassemia market